7/2/2020  9:59:55 PM Chg. +0.01 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
334.75USD 0.00% 13,764
Turnover: 4.62 mill.
-Bid Size: - -Ask Size: - 28.43 bill.USD 0.00% 67.36

Business description

IDEXX Laboratories, Inc. is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX Laboratories employs more than 7,000 people and offers products to customers in more than 175 countries.
 

Management board & Supervisory board

CEO
Jay Mazelsky
Management board
Brian P. McKeon, Giovani Twigge, Sharon E. Underberg
Supervisory board
Lawrence D. Kingsley, Bruce L. Claflin, Daniel M. Junius, Dr. Rebecca M. Henderson, Dr. Sophie V. Vandebroek, Dr. Stuart M. Essig, Jay Mazelsky, Jonathan W. Ayers, M. Anne Szostak, Sam Samad
 

Company data

Name: IDEXX Laboratories Inc.
Address: One IDEXX Drive,Westbrook, Maine 04092, USA
Phone: +1-207-556-0300
Fax: +1-207-556-4346
E-mail: -
Internet: www.idexx.com
Industry: Biotechnology
Sector: Biotechnology
Sub sector: Biotechnology
End of financial year: 12/31
Free Float: 74.89%
IPO date: -

Investor relations

Name: Kerry Bennett
IR phone: +1-207-556-8155
IR Fax: +1-207-556-4427
IR e-mail: investorrelations@idexx.com

Main Shareholders

Freefloat
 
74.89%
The Vanguard Group
 
11.01%
BlackRock, Inc.
 
8.70%
Fundsmith LLP
 
5.40%